FDA approves marketing of head injury assessment tests
On Aug. 22, the U.S. Food and Drug Administration announced that two computerized devices used to assess a patient's cognitive function following a brain injury have been approved for marketing in Florida and nationwide. In a press release, the agency said the devices are intended to help doctors evaluate the signs and symptoms of concussions [...]